窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Sep 4 2020

Full Issue

'Very, Very Low Chance': Top Vaccine Adviser Downplays Chance Of Early Approval

Dr. Moncef Slaoui, the chief scientific adviser for the White House's "Operation Warp Speed" vaccine program, spoke to NPR about the possibility that a COVID-19 vaccine could be granted Emergency Use Authorization before final clinical trials wrap up: "I think it's extremely unlikely but not impossible."

The Centers for Disease Control and Prevention is asking states to have a plan in place to distribute a COVID-19 vaccine as soon as late October but that doesn't mean an effective treatment will be ready quite so soon. In separate interviews Thursday with NPR, the chief scientific adviser to the Trump administration's vaccine development effort and the former director of the CDC's office of public health preparedness cautioned that an effective vaccine is likely still months away. (Silva, 9/3)

Dr. Slaoui confirmed that the two main candidates, referred to as Vaccine A and Vaccine B, were being developed by Pfizer and Moderna. He said that there was no intent to introduce a vaccine before clinical trials were completed, and that trials would only be completed when an independent safety monitoring board, separate from the government, affirmed the effectiveness of the vaccine. (9/3)

Talking to ScienceInsider today, Slaoui insisted he wont be swayed by political pressures to rush an unsafe or ineffective vaccine, and that science will carry the dayor hell quit. Slaoui has given few interviews since taking the Warp Speed job and he has taken something of a beating in the media for his financial holdings in companies working on COVID-19 vaccineshe was on the board of Moderna and has since stepped down, but he retains his GlaxoSmithKline stock. And Warp Speed has been slammed for a lack of transparency on its decisions. (Cohen, 9/3)

Dr. Anthony Fauci weighs in

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Thursday that he believes federal regulators will allow a coronavirus vaccine to be distributed this fall only if its based on science and hard data. Fauci made the assessment after the disclosure of an Aug. 27 letter from the Centers for Disease Control and Prevention that told states to prepare for the large-scale distribution of a vaccine by Nov. 1, two days before the presidential election. (Stelloh and Allen, 9/3)

Anthony Fauci, the nations leading infectious diseases expert, said he would feel comfortable taking a coronavirus vaccine if one is approved by the government.I mean I will look at the data and I would assume and Im pretty sure its going to be the case that a vaccine would not be approved for the American public unless it was indeed both safe and effective. And I keep emphasizing both safe and effective. If thats the case, Jim, I would not hesitate for a moment to take the vaccine myself and recommend it for my family, he told CNN anchor Jim Sciutto on Thursday. (Axelrod, 9/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, June 12
  • Thursday, June 11
  • Wednesday, June 10
  • Tuesday, June 9
  • Monday, June 8
  • Friday, June 5
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF